Soleno Therapeutics expands inducement equity plan by 500,000 shares for new hires

SOLENO THERAPEUTICS INC

Board added 500,000 shares to 2020 Inducement Plan on January 24, 2024.
Plan used to grant equity awards as material inducement for new employees and M&A hires.
Amendment adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4).
Total shares authorized under the Plan now 2,500,000.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.